Vimarsana
Biggest News Aggregation in the World

Page 3 - Long Term Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Long Term Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Long Term Data Today - Breaking & Trending Today

Beatles, Butterflies Population Thriving While Some Insects Decline in Numbers - Vimarsana News

Beatles, Butterflies Population Thriving While Some Insects Decline in Numbers

Insects have been studied in over 900 locations throughout the world in a new meta-study that examines long-term data.

New Dupixent® (dupilumab) Analyses at Two Upcoming Dermatology Congresses Reinforce Long-term Safety and Efficacy Profile in Patients with Atopic Dermatitis as Young as 6 Years - Vimarsana News

New Dupixent® (dupilumab) Analyses at Two Upcoming Dermatology Congresses Reinforce Long-term Safety and Efficacy Profile in Patients with Atopic Dermatitis as Young as 6 Years

Share this article TARRYTOWN, N.Y., April 23, 2021 /PRNewswire/ --  Nearly 30 data presentations at AAD and ESPD highlight the impact of Dupixent on disease measures including rapid itch relief and sustained improvement in disease severity, as well as quality of life in clinical and real-world settings Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that new analyses of Dupixent ® (dupilumab) in patients as young as 6 years with moderate-to-severe atopic dermatitis will be presented at the American Academy of Dermatology Annual Meeting (AAD VMX 2021) from April 23-25, and at ...

Gilead's HIV therapy Biktarvy demonstrates long-term sustained efficacy - Vimarsana News

Gilead's HIV therapy Biktarvy demonstrates long-term sustained efficacy

Data from two Phase III studies demonstrated durable viral suppression in HIV-1 patients - News - PharmaTimes